The 94 rating InvestorsObserver gives to Mereo BioPharma Group plc - ADR (MREO) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 100 percent of stocks in the Biotechnology industry, MREO’s 94 overall rating means the stock scores better than 94 percent of all stocks.
MREO has an Overall Score of 94. Find out what this means to you and get the rest of the rankings on MREO!